Status:

RECRUITING

Autologous Platelet Rich Plasma Intraovarian Infusion for Poor Responders

Lead Sponsor:

Genesis Athens Clinic

Collaborating Sponsors:

National and Kapodistrian University of Athens

Conditions:

Poor Response to Ovulation Induction

Infertility, Female

Eligibility:

FEMALE

35-47 years

Phase:

PHASE2

PHASE3

Brief Summary

Autologous platelet rich plasma (PRP) intraovarian infusion may improve ovarian response to controlled ovarian stimulation as well as the hormonal profile of poor ovarian response infertile women subj...

Detailed Description

Despite recent advances in reproductive medicine, poor ovarian response (POR) management is still considered to be very challenging. Commonly, POR patients present with reduced ovarian reserve and poo...

Eligibility Criteria

Inclusion

  • Poor Ovarian Response according to Bologna Criteria (fulfilling 2 out of 3 of the following):
  • Age ≥ 40 years
  • AMH \< 1.1 ng/ml OR AFC \< 7
  • ≤ 3 oocytes with a conventional stimulation protocol
  • Discontinuation of any complementary/adjuvant treatment including hormone replacement and acupuncture, for at least three months prior to recruitment.
  • Willing to comply with study requirements

Exclusion

  • Any pathological disorder related to reproductive system anatomy
  • Cycle irregularities
  • Amenorrhea
  • Endometriosis
  • Adenomyosis
  • Fibroids and adhesions
  • Infections in reproductive system
  • Current or previous diagnosis of cancer in reproductive system
  • History of familiar cancer in reproductive system
  • Severe male factor infertility
  • Prior referral for Preimplantation Genetic Testing (PGT) -Ovarian inaccessibility -Endocrinological disorders (Hypothalamus-
  • Pituitary disorders, thyroid dysfunction, diabetes mellitus, metabolic syndrome)
  • BMI\>30 kg/m2 or BMI\<18.5 kg/m2
  • Systematic autoimmune disorders

Key Trial Info

Start Date :

January 23 2019

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

January 31 2026

Estimated Enrollment :

100 Patients enrolled

Trial Details

Trial ID

NCT05181748

Start Date

January 23 2019

End Date

January 31 2026

Last Update

December 27 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Genesis Athens Clinic

Athens, Attica, Greece, 15232